申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US05858995A1
公开(公告)日:1999-01-12
This invention relates to a novel heterocyclic compound represented by formula (I), wherein each symbol is as defined in the specification and a pharmaceutically acceptable salt thereof which are the inhibitors of bone resorption and bone metabolism, to processes for preparation thereof, to a pharmaceutical composition comprising the same and to a method for the treatment of diseases caused by abnormal bone metabolism in human being or an animal.
这项发明涉及一种由式(I)表示的新型杂环化合物,其中每个符号如规范中定义的,并且其药学上可接受的盐,这些化合物是骨吸收和骨代谢的抑制剂,涉及其制备方法,包括相同化合物的药物组合物,以及用于治疗人类或动物因异常骨代谢引起的疾病的方法。